Approval · Notice of Compliance 23738 · 2020
REVATIO: Notice of Compliance 23738
Issued June 5, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23738
- Date
- June 5, 2020
- Company
- Upjohn Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative: Change in Product Ownership, Updates to the product monograph,Inner and outer labels and package insert.
Products in this notice
Medicinal ingredients
- SILDENAFIL CITRATE 20 MG per TAB
- SILDENAFIL CITRATE 0.8 MG per ML